Cargando…
Mucopolysaccharidoses type I gene therapy
Mucopolysaccharidoses type I (MPS I) is an inherited metabolic disease characterized by a malfunction of the α‐l‐iduronidase (IDUA) enzyme leading to the storage of glycosaminoglycans in the lysosomes. This disease has longtime been studied as a therapeutic target for those studying gene therapy and...
Autores principales: | Hurt, Sarah C., Dickson, Patricia I., Curiel, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525653/ https://www.ncbi.nlm.nih.gov/pubmed/34189746 http://dx.doi.org/10.1002/jimd.12414 |
Ejemplares similares
-
Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art
por: de Castro, María José, et al.
Publicado: (2021) -
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
por: Tomatsu, Shunji, et al.
Publicado: (2015) -
Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018) -
Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021) -
ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018)